Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study

BACKGROUND: Aggressive non-melanoma skin cancer (deeply infiltrating, recurrent, and morphea form lesions) are therapeutically challenging because they require considerable tissue loss and may demand radical disfiguring surgery. Interferons (IFN) may provide a non-surgical approach to the management...

Descripción completa

Detalles Bibliográficos
Autores principales: Anasagasti-Angulo, Lorenzo, Garcia-Vega, Yanelda, Barcelona-Perez, Silvia, Lopez-Saura, Pedro, Bello-Rivero, Iraldo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724551/
https://www.ncbi.nlm.nih.gov/pubmed/19643007
http://dx.doi.org/10.1186/1471-2407-9-262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724551/
https://www.ncbi.nlm.nih.gov/pubmed/19643007
http://dx.doi.org/10.1186/1471-2407-9-262

Ejemplares similares